NEVVI Medicare utilization intelligence

← back

RAMAEKERS, RYANMD NPI 1174539936 Clinician

Hematology-Oncology · GRAND ISLAND, NE

Specialty Hematology-Oncology — from billed Medicare claims
Trained UNIVERSITY OF NEBRASKA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 23 years since medical school (class of 2003, self-reported to CMS)
Location GRAND ISLAND, NE · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 55 codes billed · 161,080 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
ONCOLOGY HEMATOLOGY WEST PC
2022–2026
CHI HEALTH CLINIC SPECIALTY LLC
2021
THE PHYSICIAN NETWORK
2019–2020

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2013-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J9263 Injection, oxaliplatin, 0.5 mg
J1439 Injection, ferric carboxymaltose, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1434 Injection, fosaprepitant (focinvez), 1 mg
J0897 Injection, denosumab, 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J2469 Injection, palonosetron hcl, 25 mcg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0640 Injection, leucovorin calcium, per 50 mg
36415 Insertion of needle into vein for collection of blood sample
J9190 Injection, fluorouracil, 500 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
J9045 Injection, carboplatin, 50 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96372 Injection of drug or substance under skin or into muscle
J3489 Injection, zoledronic acid, 1 mg
96415 Administration of chemotherapy into vein, each additional hour
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
96361 Infusion into a vein for hydration, each additional hour
J1200 Injection, diphenhydramine hcl, up to 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96411 Administration of additional new drug or substance into vein using push technique
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
96360 Infusion into a vein for hydration, 31-60 minutes
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
96523 Irrigation of implanted venous access drug delivery device
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J3490 Unclassified drugs
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month
J2997 Injection, alteplase recombinant, 1 mg
G0008 Administration of influenza virus vaccine
82565 Blood creatinine level
90662 Influenza vaccine split virus, preservative free
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
36591 Collection of blood sample from implanted device
96374 Injection of drug or substance into vein
36593 Declotting of central venous tube
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
G0023 Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities: person-centered assessmen

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.